Indaptus Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.5% | -21.5% | -19.0% |
| FY2022 | -58.2% | -58.2% | -51.0% |
| FY2023 | -127.7% | -127.7% | -103.3% |
| FY2024 | -380.8% | -380.8% | -204.7% |
| FY2025 | -661.5% | -661.5% | -223.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.5% | -21.5% | -19.0% |
| FY2022 | -58.2% | -58.2% | -51.0% |
| FY2023 | -127.7% | -127.7% | -103.3% |
| FY2024 | -380.8% | -380.8% | -204.7% |
| FY2025 | -661.5% | -661.5% | -223.9% |